GBI Research is a market-leading provider of business intelligence reports. GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leadersà insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.Headquartered in the UK, the company has branches in the US and Asia, and provides world class client support and service.

Page

Chronic Respiratory Disease Drug Development Pipeline Review, 2018

By GBI Research | Pharmaceuticals and Healthcare | Nov 2018 | Page 361

Chronic Respiratory Disease Drug Development Pipeline Review, 2018 This report provides an overview of the pipeline landscape for chronic respiratory diseases. It provides comprehensive information on the....

USD 3995 View Report

Transplant Complications Drug Development Pipeline Review, 2018

By GBI Research | Pharmaceuticals and Healthcare | Nov 2018 | Page 173

Transplant Complications Drug Development Pipeline Review, 2018 This report provides an overview of the pipeline landscape for transplant complications. It provides comprehensive information on the therapeutics under....

USD 3995 View Report

Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

By GBI Research | Pharmaceuticals and Healthcare | Nov 2018 | Page 113

Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies Atopic dermatitis (AD), also called atopic....

USD 4995 View Report

Epilepsy Therapeutics in Asia-Pacific Markets to 2024 - Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth

By GBI Research | Pharmaceuticals and Healthcare | Nov 2018 | Page 120

Epilepsy Therapeutics in Asia-Pacific Markets to 2024 - Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth Epilepsy is a chronic disorder of....

USD 4995 View Report

Optic Nerve Disorders Drug Development Pipeline Review, 2018

By GBI Research | Pharmaceuticals and Healthcare | Oct 2018 | Page 149

Optic Nerve Disorders Drug Development Pipeline Review, 2018 This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve....

USD 3995 View Report